Cubist Systematic Strategies, LLC Dbv Technologies S.A. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.3 - $1.88 $3,519 - $5,089	2,707 New	2,707 $3,000
Q1 2020 May 15, 2020	SELL	$2.33 - $12.98 $55,374 - $308,482	-23,766 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.75 - $11.15 $130,045 - $214,815	19,266 Added 428.13%	23,766 $254,000
Q3 2019 Nov 14, 2019	SELL	$8.57 - $10.72 $75,278 - $94,164	-8,784 Reduced 66.12%	4,500 $39,000
Q2 2019 Aug 14, 2019	BUY	$7.58 - $10.0 $9,315 - $12,290	1,229 Added 10.19%	13,284 $109,000
Q1 2019 May 15, 2019	BUY	$5.81 - $9.37 $70,039 - $112,955	12,055 New	12,055 $93,000
Q4 2017 Feb 14, 2018	SELL	$20.9 - $49.36 $65,082 - $153,707	-3,114 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$39.62 - $46.17 $123,376 - $143,773	3,114	3,114 $132,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $95.8M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.